UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 3, 2011

 

 

BRISTOL-MYERS SQUIBB COMPANY

(Exact name of registrant as specified in its charter)

 

 

 

Delaware		1-1136		22-079-0350
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

345 Park Avenue

New York, NY, 10154

(Address of Principal Executive Office)

Registrant’s telephone number, including area code: (212) 546-4000

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

---

Item 5.07. Submission of Matters to a Vote of Security Holders.

(a.) The annual meeting of stockholders (the “Annual Meeting”) of Bristol-Myers Squibb Company (the “Company”) was held on May 3, 2011.

(b.) Stockholders voted on the matters set forth below.

Item 1. The Stockholders elected each of the Company’s 12 nominees to serve as directors of the Company until the 2012 Annual Meeting based upon the following votes:

 

Name		Votes For				Votes Against				Abstentions				Broker Non-Votes
Lamberto Andreotti			1,148,754,789				9,740,188				4,939,926				293,916,879
Lewis B. Campbell			1,104,860,075				53,434,687				5,140,141				293,916,879
James M. Cornelius			1,145,582,169				12,582,419				5,270,315				293,916,879
Louis J. Freeh			1,045,917,815				105,241,901				12,275,187				293,916,879
Laurie H. Glimcher, M.D.			1,080,347,589				78,037,356				5,049,958				293,916,879
Michael Grobstein			1,118,208,899				39,936,408				5,289,596				293,916,879
Leif Johansson			1,107,180,594				50,975,693				5,278,616				293,916,879
Alan J. Lacy			1,116,548,476				41,594,085				5,292,342				293,916,879
Vicki L. Sato, Ph.D.			1,091,181,255				67,156,310				5,097,338				293,916,879
Elliott Sigal, M.D., Ph.D.			1,148,402,514				9,798,871				5,233,518				293,916,879
Togo D. West, Jr.			1,115,250,523				42,578,044				5,606,336				293,916,879
R. Sanders Williams, M.D.			1,097,478,963				60,736,308				5,219,632				293,916,879

Item 2. The appointment of Deloitte & Touche LLP as independent registered public accounting firm for the Company for the 2011 year was ratified based upon the following votes:

 

Votes For				Votes Against				Abstentions
	1,417,820,036				34,327,872				5,203,874

Item 3. The management proposal on the advisory vote on the compensation of our named executive officers was approved based upon the following votes:

 

Votes For				Votes Against				Abstentions				Broker Non-Votes
	1,091,146,763				60,179,042				12,109,098				293,916,879

Item 4. The management proposal on the advisory vote on the frequency of the advisory vote on the compensation of our named executive officers received the following votes:

 

3 Years				2 Years				1 Year				Abstentions				Broker Non-Votes
	508,247,522				20,597,353				625,045,481				9,544,547				293,916,879

Item 5. The stockholder proposal on executive compensation disclosure received the following votes:

 

Votes For				Votes Against				Abstentions				Broker Non-Votes
	85,828,347				1,068,522,331				9,084,225				293,916,879

Item 6. The stockholder proposal on the stockholder action by written consent received the following votes:

 

Votes For				Votes Against				Abstentions				Broker Non-Votes
	444,383,389				705,361,618				13,689,896				293,916,879

---

Item 7. The stockholder proposal on pharmaceutical price restraint received the following votes:

 

Votes For		Votes Against		Abstentions		Broker Non-Votes
33,328,253		887,853,921		242,252,729		293,916,879

(d.) A majority of the votes cast by stockholders voted, on an advisory basis, to hold an advisory vote on the compensation of our named executive officers every year. The Board of Directors has taken into consideration the views of our stockholders and decided that it will include an advisory stockholder vote on the compensation of our named executive officers in the Company’s proxy materials annually until the next required vote on the frequency of such an advisory vote.

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: May 6, 2011